Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan

Busulfan (Bu) combined with cyclophosphamide (Cy) is commonly used as a myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT). There is inter-individual variability of Bu pharmacokinetics (PK) and hence in toxicity and efficacy. The introduction of therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Seydoux, Claire, Uppugunduri, Chakradhara Rao Satyanarayana, Medinger, Michael, Nava, Tiago, Halter, Joerg, Heim, Dominik, Chalandon, Yves, Schanz, Urs, Nair, Gayathri, Cantoni, Nathan, Passweg, Jakob R., Ansari, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325946/
https://www.ncbi.nlm.nih.gov/pubmed/37085674
http://dx.doi.org/10.1038/s41409-023-01963-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325946/
https://www.ncbi.nlm.nih.gov/pubmed/37085674
http://dx.doi.org/10.1038/s41409-023-01963-z

Ejemplares similares